Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells-Reference-Cited by-同舟云学术

Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells

Published:2010-01 Issue:5-6 Volume:86 Page:214-223
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Bai Xiao-Ming,Jiang Hui,Ding Jing-Xian,Peng Tao,Ma Juan,Wang Yao-Hui,Zhang Li,Zhang Hai,Leng Jing

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference51 articles.

1. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells;Asanuma;Cancer Research,2005

2. Correlation between survivin expression and prognosis in non-small cell lung cancer;Atikcan;Respiratory Medicine,2006

3. Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells;Bai;Oncology Reports,2009

4. PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells;Baratelli;Journal of Leukocyte Biology,2005

5. Survivin expression in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence;Barnes;British Journal of Cancer,2006

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EP2/EP4 targeting prevents tumor-derived PGE2-mediated immunosuppression in cDC2s;Journal of Leukocyte Biology;2024-07-23

2. Targeting cyclooxygenase-2 for chemoprevention of inflammation-associated intestinal carcinogenesis: An update;Biochemical Pharmacology;2024-05

3. A Review of the Potential Role of CoQ10 in the Treatment of Hepatocellular Carcinoma;Biochemical Genetics;2023-08-26

4. Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development;Frontiers in Physiology;2023-02-02

5. Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells;Frontiers in Oncology;2023-01-27